pXD024 - pLKO-EF1a-GFP-P2A-FLuc-WPRE Citations (1)

Originally described in: A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy.
Ye L, Park JJ, Peng L, Yang Q, Chow RD, Dong MB, Lam SZ, Guo J, Tang E, Zhang Y, Wang G, Dai X, Du Y, Kim HR, Cao H, Errami Y, Clark P, Bersenev A, Montgomery RR, Chen S Cell Metab. 2022 Apr 5;34(4):595-614.e14. doi: 10.1016/j.cmet.2022.02.009. Epub 2022 Mar 10. PubMed Journal

---

Articles Citing pXD024 - pLKO-EF1a-GFP-P2A-FLuc-WPRE

Articles
Protocol for preclinical evaluation of locoregionally delivered CAR T cells in patient-derived xenograft models of brain tumors. Draper B, Bowers C, Vassalou E, Greppi A, Anderson J, Ahmed N, Taylor MD, Donovan LK. STAR Protoc. 2024 Jun 21;5(2):103078. doi: 10.1016/j.xpro.2024.103078. Epub 2024 May 21. PubMed

If you have published an article using this material, please email us at to have your article added to this page.